Al's Comment:

Two items of note:

1. The manufacturing  plant is ready! Just waiting for the final approval.

2. We are getting close to getting the long awaited results of the DCVAX phase 3 trial for glioblastoma. 

It is a great sign that they put the money into getting the plant ready - shows confidence that the vaccine will show success! 

DCVAX is a custom made vaccine that treats the tumor. This version is for Glioblastomas but the concept should be able to be applied to any type of cancer. I am happy they chose Glioblastoma as the first target - that is the hardest, and if they can make progress there, the other cancers should be easier!  I will let you know as soon as the data is released!


Posted on: 05/16/2021

UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics

 


Click HERE to return to brain tumor news headlines.